Submitted by Anonymous (not verified) on 12 January 2026 - 13:15
Human medicines European public assessment report (EPAR): Bosulif, bosutinib, Date of authorisation: 27/03/2013, Revision: 29, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Bosulif, bosutinib, Date of authorisation: 27/03/2013, Revision: 29, Status: Authorised